InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
Puromycin | Generation of KCNH2 heterozygous knockout induced pluripotent stem cell (iPSC... | 2024 | Stem Cell Res. | Wang B. et al. | DOI: 10.1016/j.scr.2024.103400 |
Plasmocin® - Mycoplasma Elimination Reagent | N6-isopentenyladenosine inhibits aerobic glycolysis in glioblastoma cells by ... | 2024 | FEBS Open Bio. | Pagano C. et al. | DOI: 10.1002/2211-5463.13766 |
Puromycin | Molecular basis promoting centriole triplet microtubule assembly. | 2024 | Nat Commun. | Takeda Y. et al. | DOI: 10.1038/s41467-024-46454-x |
Hygromycin B Gold | Molecular basis promoting centriole triplet microtubule assembly. | 2024 | Nat Commun. | Takeda Y. et al. | DOI: 10.1038/s41467-024-46454-x |
Nano-SiO2 | Novel chemotype NLRP3 inhibitors that target the CRID3-binding pocket with hi... | 2024 | Life Sci Alliance | Vande Walle L. et al. | DOI: 10.26508/lsa.202402644 |
LFn-Needle | Novel chemotype NLRP3 inhibitors that target the CRID3-binding pocket with hi... | 2024 | Life Sci Alliance | Vande Walle L. et al. | DOI: 10.26508/lsa.202402644 |
R848 (Resiquimod) | Novel chemotype NLRP3 inhibitors that target the CRID3-binding pocket with hi... | 2024 | Life Sci Alliance | Vande Walle L. et al. | DOI: 10.26508/lsa.202402644 |
LPS-SM Ultrapure (LPS from S. minnesota R595) | Novel chemotype NLRP3 inhibitors that target the CRID3-binding pocket with hi... | 2024 | Life Sci Alliance | Vande Walle L. et al. | DOI: 10.26508/lsa.202402644 |
Pam3CSK4 | Novel chemotype NLRP3 inhibitors that target the CRID3-binding pocket with hi... | 2024 | Life Sci Alliance | Vande Walle L. et al. | DOI: 10.26508/lsa.202402644 |
ATP | Mechanism of Nicotiflorin in San-Ye-Qing rhizome for anti-inflammatory effect... | 2024 | Phytomedicine | Ruan Y. et al. | DOI: 10.1016/j.phymed.2024.155564 |
LPS-B5 (LPS from E. coli O55:B5) | Mechanism of Nicotiflorin in San-Ye-Qing rhizome for anti-inflammatory effect... | 2024 | Phytomedicine | Ruan Y. et al. | DOI: 10.1016/j.phymed.2024.155564 |
Primocin® | Accessible luminal interface of bovine rectal organoids generated from cryopr... | 2024 | PLoS One | Kawasaki M. & Ambrosini Y.M. | DOI: 10.1371/journal.pone.0301079 |
Primocin® | Comparison of Minced Cartilage Implantation with Autologous Chondrocyte Trans... | 2024 | Cells | Ossendorff R. et al. | DOI: 10.3390/cells13060546 |
LPS-PG (Lipopolysaccharide from P. gingivalis) | Proteomic analysis of P. gingivalis-Lipopolysaccharide induced neuroinflammat... | 2024 | Geroscience | Verma A. et al. | DOI: 10.1007/s11357-024-01117-z |
Normocin® - Antimicrobial Reagent | Feedback activation of CD73-Adenosine axis attenuates the antitumor immunity ... | 2024 | BBRC | Fu N. et al. | DOI: 10.1016/j.bbrc.2024.149814 |
Zeocin® | Targeted degradation of zDHHC-PATs decreases substrate S-palmitoylation. | 2024 | PLoS One | Bai M. et al. | DOI: 10.1371/journal.pone.0299665 |
Blasticidin | Targeted degradation of zDHHC-PATs decreases substrate S-palmitoylation. | 2024 | PLoS One | Bai M. et al. | DOI: 10.1371/journal.pone.0299665 |
Hygromycin B Gold | Targeted degradation of zDHHC-PATs decreases substrate S-palmitoylation. | 2024 | PLoS One | Bai M. et al. | DOI: 10.1371/journal.pone.0299665 |
Jurkat Reporter Cells (NFAT) | Galectin 7 leads to a relative reduction in CD4+ T cells, mediated by PD-1. | 2024 | Sci Rep. | Wu G. et al. | DOI: 10.1038/s41598-024-57162-3 |
QUANTI-Luc™: Luciferase Detection Reagent | Galectin 7 leads to a relative reduction in CD4+ T cells, mediated by PD-1. | 2024 | Sci Rep. | Wu G. et al. | DOI: 10.1038/s41598-024-57162-3 |